sinha et al. 2018 liposomal glutathione eur j clin nutr A Targeted Metabolomic Assessment of Oral Bioavailability and Safety in Humans: A Randomized Crossover Clinical Trial Liposomal glutathione outperforms plain glutathione

Evolocumab and Clinical Outcomes in Patients with Cardiovascular Disease (primary endpoint analysis)

HPA Axis Modulation Research reveals DSIPs regulatory effects on the hypothalamic-pituitary-adrenal axis: Decreased cortisol production during stress Normalized blood pressure responses Improved myocardial contraction patterns Enhanced stress adaptation capacity Growth Hormone Interactions Studies indicate DSIP stimulates somatoliberin and somatotropin release while inhibiting somatostatin secretion[8]

[DOI] [PMC free article] [PubMed] [Google Scholar] 75.Garg S, Vitvitsky V, Gendelman HE, Banerjee R

Additionally, a systematic review found that patients on orforglipron had significantly better weight loss outcomes, achieving reductions of 5%, 10%, and 15%

doi:10.1093/gerona/glac135

Sample sizes were small which can lead to misleading conclusions especially regarding correlations with subjective sensations and questionnaire results that have small effect sizes